bioharvest.com (BHST) Company Cash Funds

Graphic logo of BioHarvest Sciences Inc. (BHST)

BioHarvest Sciences (BHST) is implementing automated plant cell synthesis systems, replacing manual labor with bioreactors. The free cash flow metric visualizes liquidity for obligations, where the 0.01 mark reflects the latest data. However, scaling and certification challenges are hindering expansion. Meanwhile, the ecological approach minimizes the use of water resources and land when producing bio-assets.

BioHarvest Sciences, Inc. - BHST Company Cash Funds (period 11/13/2024 - 11/21/2026)

Analytical breakdowns and data insights for company BioHarvest (BHST)

Summary company analysis:BioHarvest Sciences BHST
Signature product of BioHarvest Sciences, Inc.

Free cash flow determines the financial stability of a company and its ability to grow without external borrowing. For BioHarvest Sciences (BHST), which is scaling bioreactor production of plant cells, the cash asset volume reflects the resource base for innovation expansion. The current value of 0.01 allows for an assessment of liquidity reserves relative to business growth rates. Analyzing this metric helps investors distinguish a strategic reserve from capital stagnation.

Direct competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance